Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT

Stereotactic body radiotherapy (SBRT) is an established treatment option in the management of patients with early-stage non-small cell lung cancer (NSCLC). Prospective studies have demonstrated that SBRT achieves high rates of local tumor control [1 –3]. Compared to conventionally-fractionated radiotherapy (CFRT) for early stage NSCLC, SBRT is associated with equivalent tumor control, shortened treatment times, and decreased toxicity, with larger retrospective studies even suggesting a survival benefit [4–7].

Source: Radiotherapy and Oncology - August 30, 2019 Category: Radiology Authors: William R. Kennedy, Prashant Gabani, John Nikitas, Clifford G. Robinson, Jeffrey D. Bradley, Michael C. Roach Tags: Original Article Source Type: research